Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15057674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.

  2002cited by this paper
• Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

  2000cited by this paper
• Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.

  2000cited by this paper
• The use of fixed-mixture insulins in clinical practice

  2000cited by this paper
• Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group.

  1999cited by this paper
• Time-Action Profiles of Novel Premixed Preparations of Insulin Lispro and NPL Insulin

  1998cited by this paper
• Use of the short‐acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time‐interval injection‐meal

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group.

  1997cited by this paper
• Mathematical Descriptions of the Glucose Control in Diabetes Therapy. Analysis of the Schlichtkrull “M”-Value

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

  1994cited by this paper
• Dosage accuracy of self-mixed vs premixed insulin.

  1991cited by this paper
• How Accurate Are Insulin Mixtures Prepared by the Patient?

  1986cited by this paper
• The use of non-parametric methods in the statistical analysis of the two-period change-over design.

  1972cited by this paper

• Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.

  2018cites this paper
• Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

  2016cites this paper
• Clinical use and efficacy of biphasic insulin lispro 50/50 in people with insulin treated diabetes – a nationwide evaluation of clinical practice

  2015cites this paper
• High-mix insulins

  2015cites this paper
• Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus

  2014cites this paper
• Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study

  2014cites this paper
• A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus

  2014cites this paper
• The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus

  2012cites this paper
• Humalog (lispro) for type 2 diabetes

  2012cites this paper
• Iatrogenic Hypoglycemia in Patients with Type 2 Diabetes: Comparison of Insulin Analog Premixes and Human Insulin Premixes

  2011cites this paper
• Insulin Analogs and Glycosylated Hemoglobin Target of Less Than 7% in Type 2 Diabetes: A Systematic Review of Randomized Trials

  2011cites this paper
• Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta‐analysis of randomised controlled trials

  2011cites this paper
• Mid‐ and high‐ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control

  2010cites this paper
• Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease

  2010cites this paper
• Effects of Twice-Daily Injections of Premixed Insulin Analog on Glycemic Control in Type 2 Diabetic Patients

  2010cites this paper
• Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes

  2009cites this paper
• Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

  2009cites this paper
• Insulin therapy in type 2 diabetes: what is the evidence?

  2009cites this paper
• Guideline for management of postmeal glucose.

  2008cites this paper
• Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes

  2008cites this paper
• Type 2 diabetes mellitus--guidelines for initiating insulin therapy.

  2007cites this paper
• Canadian Agency for Drugs and Technologies in Health Short-acting Insulin Analogues for Diabetes Mellitus

  2007cites this paper
• Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen Failure

  2007cites this paper
• Two regimens of twice-daily premix insulin analogue: an observational study.

  2006cites this paper
• A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Improvement of glucose tolerance in type 2 diabetic patients: traditional vs. modern insulin regimens (results from the Austrian Biaspart Study).

  2005cites this paper